Pharmacotherapy of canine atopic dermatitis - current state and new trends

Wolfgang BÄUMER

doi:https://doi.org/10.33988/auvfd.644485

Makale detayları

Pharmacotherapy of canine atopic dermatitis - current state and new trends

Yazarlar:

Wolfgang BÄUMER

Ana Başlıklar:

Hayvancılık

Dergi:

Ankara Üniversitesi Veteriner Fakültesi Dergisi 2020 Vol.67 Issue 1, pp.107-111

Belge Tipi:

Makale

Yayın Tarihi:

12/2019

Belge Dili:

İngilizce

Document ID (Org No.):

2000849566

DOI:

https://doi.org/10.33988/auvfd.644485

Özet:

 


This review offers a concise overview of current treatment options for
canine atopic dermatitis and provide an outline of two promising new treatment
options (phosphodiesterase 4 and histamine H4 receptor inhibitors).
Glucocorticoids have been one of the first successful treatment options and are
still part of the treatment regime. Ciclosporin was introduced more than 15
years ago and is also a main pharmacological treatment option. In 2013, the
Janus kinase inhibitor oclacitinib was introduced as a first in class, which is
then followed by the anti-canine IL-31 antibody lokivetmab in 2016. Thus,
exciting new treatment options have found their way into clinical practice.
Apart from these substance classes, antihistamines, essential fatty acids and
lipid substitution will be discussed as add-on treatments.


.

Makale detayları

Pharmacotherapy of canine atopic dermatitis - current state and new trends

Yazarlar: Wolfgang BÄUMER

Ana Başlıklar: Hayvancılık

Dergi: Ankara Üniversitesi Veteriner Fakültesi Dergisi 2020 Vol.67 Issue 1, pp.107-111

Belge Tipi: Makale

Yayın Tarihi: 12/2019

Belge Dili: İngilizce

Document ID (Org No.): 2000849566

DOI: https://doi.org/10.33988/auvfd.644485

Sayı

Yazarlar:

Wolfgang BÄUMER

Ana Başlıklar:

Hayvancılık

Dergi:

Ankara Üniversitesi Veteriner Fakültesi Dergisi 2020 Vol.67 Issue 1, pp.107-111

Belge Tipi:

Makale

Yayın Tarihi:

12/2019

Belge Dili:

İngilizce

Document ID (Org No.):

2000849566

DOI:

https://doi.org/10.33988/auvfd.644485